References
- Adeyemo, A., and Rotimi, C., 2010. Genetic variants associated with complex human diseases show wide variation across multiple populations, Public Health Genomics 13 (2010), pp. 72–79.
- Alpert, S., 2008. Privacy issues in clinical genomic medicine, or Marcus Welby, M.D., meets the $1000 genome, Cambridge Quarterly of Healthcare Ethics 17 (2008), pp. 373–384.
- Altshuler, D., and Daly, M., 2007. Guilt beyond a reasonable doubt, Nature Genetics 39 (7) (2007), pp. 813–815.
- American College of Medicine Genetics, 2004. ACMG statement on direct-to-consumer genetic testing, Genetics in Medicine 6 (1) (2004), 60.
- American College of Obstetricians and Gynecologists, 2008. Direct-to-consumer marketing of genetic testing, Obstetrics & Gynecology 111 (6) (2008), pp. 1493–1494.
- Angrist, M., 2010. Here is a human being: at the dawn of personal genomics. New York: HarperCollins; 2010.
- Beauchamp, T. L., and Childress, J. F., 2009. Principles of biomedical ethics. New York: Oxford University Press; 2009.
- Bennis, W., Goleman, D., and O'toole, J., 2008. Transparency: how leaders create a culture of candor. San Francisco: Jossey-Bass; 2008.
- Berenson, R. A., and Cassel, C. K., 2009. Consumer-driven health care may not be what patients need – caveat emptor, Journal of the American Medical Association 301 (3) (2009), pp. 321–323.
- Berg, C., and Fryer-Edwards, K., 2007. The ethical challenges of direct-to-consumer genetic testing, Journal of Business Ethics 77 (2007), pp. 17–31.
- Burke, W., and Psaty, B. M., 2007. Personalized medicine in the era of genomics, Journal of the American Medical Association 298 (14) (2007), pp. 1682–1684.
- Burke, W., Laberge, A.-M., and Press, N., 2010. Debating clinical utility, Public Health Genomics 13 (2010), pp. 215–223.
- Cameron, L. D., et al., 2009. Impact of genetic risk information and type of disease on perceived risk, anticipated affect, and expected consequences of genetic tests, Health Psychology 28 (3) (2009), pp. 307–316.
- Caulfield, T., 2009. Direct-to-consumer genetics and health policy: a worst-case scenario?, American Journal of Bioethics 9 (6–7) (2009), pp. 48–50.
- Collins, F. S., 2010. The language of life. New York: HarperCollins; 2010.
- Darcé, K., 2010. "Genetics test sellers come under fire". In: San Diego Union-Tribune. 2010, 23 July, p. A1.
- Davies, K., 2010. The $1,000 genome. New York: Free Press; 2010.
- Department of Health and Human Services, 2008. US System of oversight of genetic testing: a response to the charge of the Secretary of Health and Human Services. Report of the Secretary's Advisory Committee on Genetics, Health, and Society. Washington: Department of Health and Human Services; 2008, [online]. Available from: http://oba.od.nih.gov/oba/SACGHS/reports/SACGHS_oversight_report.pdf [Accessed 10 November 2010].
- Department of Health and Human Services, 2009. GINA: The Genetic Information Nondiscrimination Act of 2008: information for researchers and health care professionals. Washington: Department of Health and Human Services; 2009, [online]. Available from: http://www.genome.gov/Pages/PolicyEthics/GeneticDiscrimination/GINAInfoDoc.pdf [Accessed 11 November 2010].
- Duke, J., Friedlin, J., and Ryan, P., 2011. A quantitative analysis of adverse events and “overwarning” in drug labeling, Archives of Internal Medicine 171 (10) (2011), pp. 944–946.
- Einsiedel, E. F., and Geransar, R., 2009. Framing genetic risk: trust and credibility markers in online direct-to-consumer advertising for genetic testing, New Genetics and Society 28 (4) (2009), pp. 339–362.
- Evans, J. P., and Green, R. C., 2009. Direct to consumer genetic testing: avoiding a culture war, Genetics in Medicine 11 (8) (2009), pp. 568–569.
- Farkas, D. H., and Holland, C. A., 2009. Direct-to-consumer genetic testing: two sides of the coin, Journal of Molecular Diagnostics 1 (4) (2009), pp. 263–265.
- Fung, A., Graham, M., and Weil, D., 2007. Full disclosure: the perils and promise of transparency. New York: Cambridge University Press; 2007.
- Genetics & Public Policy Center, 2010. Updated chart of direct-to-consumer genetic testing companies available. 2010, 28 May [online]. Available from http://www.dnapolicy.org/news.release.php?action=detail&pressrelease_id=137 [Accessed 30 October 2010].
- Geransar, R., and Einsiedel, E., 2008. Evaluating online direct-to-consumer marketing of genetic tests: informed choices or buyers beware?, Genetic Testing 12 (1) (2008), pp. 13–23.
- Goddard, K. A.B., et al., 2008. Health-related direct-to-consumer genetic tests: a public health assessment and analysis of practices related to Internet-based tests for risk of thrombosis, Public Health Genomics 12 (2008), pp. 92–104.
- Gollust, S. E., Hull, S. C., and Wilfond, B. S., 2002. Limitations of direct-to-consumer advertising for clinical genetic testing, Journal of American Medical Association 288 (14) (2002), pp. 1762–1767.
- Gollust, S. E., Wilfond, B. S., and Hull, S. C., 2003. Direct-to-consumer sales of genetic services on the Internet, Genetics in Medicine 5 (4) (2003), pp. 332–337.
- Gravlee, C. C., Non, A. L., and Mulligan, C. J., 2009. Genetic ancestry, social classification, and racial inequalities in blood pressure in Southeastern Puerto Rico, PLoS One 4 (9) (2009), e6821 [online]. Available from: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0006821 [Accessed 15 December 2010].
- Henderson, M., 2010. "Cashing in on your genes". In: The Times. 2010, 7 January, pp. 26–29.
- Hogarth, S., 2010. Myths, misconceptions and myopia: searching for clarity in the debate about the regulation of consumer genetics, Public Health Genomics 13 (2010), pp. 322–326.
- Hudson, K., et al., 2007. ASHG statement on direct-to-consumer genetic testing in the United States, American Journal of Human Genetics 81 (2007), pp. 635–637.
- Hunter, D. J., Khoury, M. J., and Drazen, J. M., 2008. Letting the genome out of the bottle – will we get our wish?, New England Journal of Medicine 358 (2) (2008), pp. 105–107.
- Janssens, A. C.J.W., et al., 2008. A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions, American Journal of Human Genetics 82 (2008), pp. 593–599.
- Javitt, G. H., 2006. Public implications of genetic testing: not just for geneticists anymore, Advances in Chronic Kidney Disease 13 (2) (2006), pp. 178–182.
- Jordens, C. F.C., Kerridge, I. H., and Samuel, G. N., 2009. Direct-to-consumer personal genome testing: the problem is not ignorance – it is market failure, American Journal of Bioethics 9 (6–7) (2009), pp. 13–15.
- Kraft, P., and Hunter, D. J., 2009. Genetic risk prediction – are we there yet?, New England Journal of Medicine 360 (2009), pp. 1701–1703.
- Kutz, G., 2006. "Nutrigenetic testing. Testimony before the US Senate Special Committee on Aging". 2006, US Government Accountability Office, 27 July [online]. Available from http://www.gao.gov/new.items/d06977t.pdf [Accessed 30 October 2010].
- Kutz, G., 2010. "Direct-to-consumer genetic tests. Testimony before the House Energy and Commerce subcommittee on oversight and investigations". 2010, US Government Accountability Office, 22 July [online]. Available from http://energycommerce.house.gov/documents/20100722/Kutz.Testimony.07.22.2010.pdf [Accessed 20 October 2010].
- Lewis, R., 2010. Human genetics: concepts and applications. New York: McGraw-Hill; 2010.
- Liu, Y., and Pearson, Y. E., 2008. Direct-to-consumer marketing of predictive medicine genetic tests: assessment of current practices and policy recommendations, Journal of Public Policy & Marketing 27 (2) (2008), pp. 131–148.
- Lowery, J. T., et al., 2008. The impact of direct-to-consumer marketing of cancer genetic testing on women according to their genetic risk, Genetics in Medicine 10 (12) (2008), pp. 888–894.
- Magnus, D., Cho, M. K., and Cook-Deegan, R., 2009. Direct-to-consumer tests: beyond medical regulation?, Genome Medicine 1 (2) (2009), 17.1–17.3.
- Manolio, T. A., 2010. Genomewide association studies and assessment of the risk of disease, New England Journal of Medicine 363 (2010), pp. 166–176.
- McGuire, A. L., and Burke, W., 2008. An unwelcome side effect of direct-to-consumer personal genome testing, Journal of the American Medical Association 300 (22) (2008), pp. 2669–2671.
- Morgan, M., 2010. "FDA warns companies about direct-to-consumer genetics tests". In: Neurology Today. 2010, 5 August, p. 28.
- Mykitiuk, R., 2004. Caveat emptor: direct-to-consumer supply and advertising of genetic testing, Clinical and Investigative Medicine 27 (1) (2004), pp. 23–32.
- Ng, P. C., et al., 2009. An agenda for personalized medicine, Nature 461 (7265) (2009), pp. 724–736.
- Oliver, R. W., 2004. What is transparency?. New York: McGraw-Hill; 2004.
- Pollack, A., 2010a. "Outlook uncertain". In: New York Times. 2010a, 20 March, p. B1.
- Pollack, A., 2010b. "FDA faults companies on unapproved genetic tests". In: New York Times. 2010b, 11 June, p. B2.
- Ricketts, C., 2009. "Complete Genomics seals $45M for cheaper gene sequencing". In: Venture Beat. 2009, [online]. Available from: http://venturebeat.com/2009/08/24/complete-genomics-seals-45m-for-cheaper-gene-sequencing/ [Accessed 12 November 2010].
- Reilly, P. R., Boshar, M. F., and Holtzman, S. H., 1997. Ethical issues in genetic research: disclosure and informed consent, Nature Genetics 15 (1997), pp. 16–20.
- Schwartz, P. H., 2009. The value of information and the ethics of personal-genomic screening, American Journal of Bioethics 9 (4) (2009), pp. 26–27.
- Scott, J. ([email protected]), 16 June 2010. Re: DTC company chart. Email to N. Lewis ([email protected]).
- Tamir, S., 2010. Direct-to-consumer genetic testing: ethical-legal perspectives and practical considerations, Medical Law Review 18 (2010), pp. 213–238.
- Vorhaus, D., 2010. "While you were meeting: FDA mails letters to 14 more genetic test providers". In: Genomics Law Report. 2010, [online]. Available from: http://www.genomicslawreport.com/index.php/2010/07/21/14-more-fda-letters/ [Accessed 12 November 2010].
- Wasson, K., 2009. Direct-to-consumer genomics and research ethics: should a more robust informed consent process be included?, American Journal of Bioethics 9 (6–7) (2009), pp. 56–58.
- Williams, R., 2010. Genomics in our own hands, The Lancet Neurology 9 (2010), pp. 656–657.
- Williams-Jones, B., 2003. Where there's a Web, there's a way: commercial genetic testing and the Internet, Community Genetics 6 (2003), pp. 46–57.